Bank Julius Baer & Co. Ltd Zurich bought a new position in Haleon plc (NYSE:HLN - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,765,864 shares of the company's stock, valued at approximately $39,628,000. Bank Julius Baer & Co. Ltd Zurich owned about 0.08% of Haleon at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Mesirow Financial Investment Management Inc. raised its position in shares of Haleon by 104.3% during the 4th quarter. Mesirow Financial Investment Management Inc. now owns 28,112 shares of the company's stock valued at $268,000 after buying an additional 14,349 shares in the last quarter. West Family Investments Inc. boosted its holdings in shares of Haleon by 16.8% in the 4th quarter. West Family Investments Inc. now owns 15,746 shares of the company's stock worth $150,000 after purchasing an additional 2,265 shares during the period. Callan Family Office LLC bought a new position in shares of Haleon during the 4th quarter valued at approximately $1,970,000. Vestmark Advisory Solutions Inc. increased its position in Haleon by 53.2% during the fourth quarter. Vestmark Advisory Solutions Inc. now owns 62,420 shares of the company's stock valued at $595,000 after acquiring an additional 21,673 shares during the last quarter. Finally, Lindbrook Capital LLC raised its position in Haleon by 22.6% in the 4th quarter. Lindbrook Capital LLC now owns 9,355 shares of the company's stock worth $89,000 after purchasing an additional 1,724 shares during the period. Institutional investors own 6.67% of the company's stock.
Analyst Ratings Changes
Several analysts have recently weighed in on HLN shares. Hsbc Global Res downgraded Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. HSBC reiterated a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a research report on Monday, March 3rd. Morgan Stanley cut shares of Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Finally, Sanford C. Bernstein lowered shares of Haleon from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 8th. Six research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Haleon currently has a consensus rating of "Hold" and a consensus price target of $10.95.
Get Our Latest Report on Haleon
Haleon Stock Performance
NYSE HLN traded down $0.20 on Wednesday, reaching $10.20. 8,304,294 shares of the company's stock traded hands, compared to its average volume of 6,580,343. The firm has a market cap of $46.15 billion, a price-to-earnings ratio of 29.99, a P/E/G ratio of 2.82 and a beta of 0.25. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The stock has a 50 day moving average price of $9.71 and a 200-day moving average price of $9.87. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.
Haleon (NYSE:HLN - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Equities research analysts predict that Haleon plc will post 0.43 EPS for the current fiscal year.
Haleon Increases Dividend
The firm also recently declared a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be paid a $0.1166 dividend. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. This is a positive change from Haleon's previous -- dividend of $0.05. Haleon's payout ratio is currently 58.97%.
Haleon Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Stories
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
